European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical SciencesMethylene BlueGalantamineNeural NetworksComputerAlzheimer Disease
Application of artificial neural network to determine optimum formulation development and in vitro characterization of methylene blue and galantamine loaded polymeric nanoparticles for the treatment of Alzheimer's disease.
Busra Ozturk, Huriye Demir, Mine Silindir-Gunay, Yagmur Akdag, Selma Sahin, Tugba Gulsun
Published: 202610.1016/j.ejps.2025.107364
Abstract
Alzheimer's disease is a major neurodegenerative disorder characterized by complex pathophysiology and currently lacks a curative treatment. This study aims to develop and characterize methylene blue and galantamine co-loaded PLGA nanoparticles, surf…
Preview only. Read the full abstract at the source